Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 articoli
New comprehensive review questions effectiveness of amyloid-targeting Alzheimer's drugs, igniting debate over treatment approach.
New study suggests Lilly's tirzepatide leads to more lean muscle loss compared to Novo's semaglutide, despite superior weight loss results.
Breakthrough therapy targeting hypoxic-ischemic encephalopathy in newborns receives significant funding, potentially becoming first HIE drug.
New technique enables researchers to study how proteins change shape when exposed to light, advancing structural biology research.
Researchers developed a breakthrough technique to cryopreserve cardiac endothelial cells with 95% viability for regenerative medicine.
Interrupted cooling protocols boost cell viability in cryopreservation by optimizing freeze-thaw timing and temperature control.
China-based Immorna and another startup enter clinical trials testing RNA-based CAR-T treatments for autoimmune conditions.
Breakthrough technology allows precise activation of genes in living animals using electromagnetic fields, opening new therapeutic possibilities.
Major cancer research funder increases investment in mRNA vaccine technology while other developers pull back from the field.
FDA seeks additional cardiovascular and liver safety data for Eli Lilly's newly approved obesity medication Foundayo.
Bacteriophages could offer a breakthrough solution to combat the growing crisis of antibiotic-resistant infections threatening global health.
Esplora i meccanismi molecolari della senescenza cellulare e il modo in cui le vie del p16/p21 guidano la produzione di SASP, oltre ai bersagli farmacologici senolitici all'avanguardia.
